[1]
Quist, S.R. et al. 2012. Long-term Treatment of Severe Recalcitrant Atopic Dermatitis with Omalizumab, an Anti-immuno-globulin E. Acta Dermato-Venereologica. 93, 2 (Oct. 2012), 206–208. DOI:https://doi.org/10.2340/00015555-1442.